Infekor Caution For Usage

Instructions for reconstitution: See Table 5.

Click on icon to see table/diagram/image

As for all parenteral medicinal products, inspect the reconstituted solution or suspension visually for particulate matter and discoloration prior to administration.
Intramuscular injection: After addition of the specified amount of diluent for intramuscular injection, a suspension is formed.
Intravenous bolus injection or intravenous infusion: After addition of the specified amount of diluent for intravenous bolus or infusion, a clear solution is formed. The solution should only be used if the solution is clear and practically free from particles.
Solutions and suspensions range in colour from clear to yellow coloured depending on concentration, diluent and storage conditions used. When made up for intramuscular use, it becomes off-white and opaque. When made up for intravenous administration, it may be yellowish.
Compatibility: Cefuroxime sodium (5 mg/mL) in 5% w/v or 10% w/v xylitol injection may be stored for up to 24 hours at 25°C.
Cefuroxime sodium is compatible with aqueous solutions containing up to 1% lidocaine hydrochloride.
Cefuroxime sodium is compatible with the following infusion fluids. It will retain potency for up to 24 hours at room temperature in: 0.9% Sodium Chloride Injection BP w/v; 5% Dextrose Injection BP; 0.18% w/v Sodium Chloride plus 4% Dextrose Injection BP; 5% dextrose containing 0.9% Sodium Chloride Injection; 5% dextrose containing 0.45% Sodium Chloride Injection; 5% dextrose containing 0.225% Sodium Chloride Injection; 10% Dextrose Injection; 10% Invert Sugar in Water for Injection; Ringer's injection USP; Lactated Ringer's Injection USP; M/6 Sodium Lactate Injection; Compound Sodium Lactate Injection BP (Hartmann's Solution).
The stability of cefuroxime sodium in Sodium Chloride Injection BP 0.9% w/v and in 5% Dextrose Injection is not affected by the presence of hydrocortisone sodium phosphate.